HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost-Reference-Cited by-同舟云学术

HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost

Published:2016-01-04 Issue:1 Volume:11 Page:e0145637
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Apostólico Juliana de Souza,Boscardin Silvia Beatriz,Yamamoto Márcio Massao,de Oliveira-Filho Jethe Nunes,Kalil Jorge,Cunha-Neto Edecio,Rosa Daniela Santoro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference86 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;RM Grant;N Engl J Med,2010

2. Prevention of HIV-1 infection with early antiretroviral therapy;MS Cohen;N Engl J Med,2011

3. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;JM Baeten;N Engl J Med,2012

4. Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies;NA Doria-Rose;J Virol,2009

5. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C;JM Binley;J Virol,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-Adjuvanting Calcium-Phosphate-Coated Microcrystal-Based Vaccines Induce Pyroptosis in Human and Livestock Immune Cells;Vaccines;2023-07-11

2. HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development;Current HIV/AIDS Reports;2022-01-28

3. Enhancement of immune responses by co-stimulation of TLR3 - TLR7 agonists as a potential therapeutics against rabies in mouse model;Microbial Pathogenesis;2021-08

4. CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help;Vaccines;2020-10-13

5. State‐of‐the‐art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI);Allergy;2020-04